This observation at the microscopic level is in concordance with previous PET studies using anti-CD8 radiolabeled antibodies in which more intratumoral tracer uptake was observed in B16.F10 melanoma tumors that responded to CTLA-4 therapy, whilst the non-responders displayed a more peripheral distribution in the detected signal (51). The gene discussed is CTLA4; the disease is melanoma.